1-20 of 20
Authors: Manabu Natsumeda
Journal Article
TMET-12. TARGETING AMINO ACID METABOLIC VULNERABILITIES IN GLIOMAS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii290, https://doi.org/10.1093/neuonc/noae165.1150
Published: 11 November 2024
Journal Article
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study Get access
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 828–840, https://doi.org/10.1093/neuonc/noae229
Published: 02 November 2024
Journal Article
GCT-16. LONG-TERM OUTCOMES AND COMPLICATION MANAGEMENT IN CNS GERM CELL TUMORS: INSIGHTS FROM A PHASE II HISTOPATHOLOGY-STRATIFIED TREATMENT TRIAL Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.271
Published: 18 June 2024
Journal Article
EXTH-46. SCHLAFEN11 IS A POWERFUL BIOMARKER OF CHEMOSENSITIVITY IN MEDULLOBLASTOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v235, https://doi.org/10.1093/neuonc/noad179.0899
Published: 10 November 2023
Journal Article
TMET-19. TARGETING AMINO ACID METABOLIC VULNERABILITIES IN IDH-MUTANT AND IDH-WILDTYPE GLIOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v276–v277, https://doi.org/10.1093/neuonc/noad179.1063
Published: 10 November 2023
Journal Article
CTNI-72. PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREATMENT STRATIFICATION FOR PATIENTS WITH CNS GERM CELL TUMORS: A LONG-TERM FOLLOW-UP STUDY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v94, https://doi.org/10.1093/neuonc/noad179.0354
Published: 10 November 2023
Journal Article
EXTH-03. HSP90 INHIBITION OVERCOMES RESISTANCE TO MOLECULAR TARGETED THERAPY IN BRAFV600E MUTANT HIGH-GRADE GLIOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii209, https://doi.org/10.1093/neuonc/noac209.802
Published: 14 November 2022
Journal Article
EXTH-82. THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN PEDIATRIC RHABDOID TUMORS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii228, https://doi.org/10.1093/neuonc/noac209.880
Published: 14 November 2022
Journal Article
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C Open Access
Neuro-Oncology, Volume 25, Issue 4, April 2023, Pages 687–698, https://doi.org/10.1093/neuonc/noac246
Published: 05 November 2022
Journal Article
Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin Free
Neuro-Oncology, Volume 25, Issue 5, May 2023, Pages 899–912, https://doi.org/10.1093/neuonc/noac243
Published: 23 October 2022
Journal Article
MBRS-32. TOPOISOMERASE II β INDUCES NEURONAL, BUT NOT GLIAL, DIFFERENTIATION IN MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii404, https://doi.org/10.1093/neuonc/noaa222.546
Published: 04 December 2020
Journal Article
MBRS-06. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii399–iii400, https://doi.org/10.1093/neuonc/noaa222.526
Published: 04 December 2020
Journal Article
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma? Free
Neuro-Oncology, Volume 23, Issue 2, February 2021, Pages 295–303, https://doi.org/10.1093/neuonc/noaa199
Published: 20 August 2020
Journal Article
PATH-46. NEURONAL DIFFERENTIATION IS INDUCED BY Gli3 IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi168–vi169, https://doi.org/10.1093/neuonc/noy148.701
Published: 05 November 2018
Journal Article
PATH-50. HIGH DETECTION RATE OF MYD88MUTATIONS IN CEREBROSPINAL FLUID FROM PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi169, https://doi.org/10.1093/neuonc/noy148.704
Published: 05 November 2018
Journal Article
PATH-54. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi183, https://doi.org/10.1093/neuonc/nox168.743
Published: 06 November 2017
Journal Article
HG-69CELL CULTURE CONDITIONS AFFECT DIFFUSE INTRINSIC PONTINE GLIOMA EPIGENETICS AND RESPONSE TO THERAPEUTIC AGENTS Free
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii64, https://doi.org/10.1093/neuonc/now073.65
Published: 30 May 2016
Journal Article
MTR-10PHARMACOLOGICAL NOTCH BLOCKADE IN GLIOMAS INDUCES AUTOPHAGY AND COMBINATION TREATMENT WITH AN AUTOPHAGY INHIBITOR INCREASES TUMOR CELL DEATH Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v126, https://doi.org/10.1093/neuonc/nov219.10
Published: 09 November 2015
Journal Article
PTPS-22DUAL mTOR KINASE INHIBITOR (MLN0128) MARKEDLY INDUCES GROWTH SUPPRESSION AND APOPTOSIS IN DIFFUSE INTRINSIC PONTINE GLIOMA CELL LINES Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v184, https://doi.org/10.1093/neuonc/nov228.22
Published: 09 November 2015
Journal Article
DS-02INDUCTION OF AUTOPHAGY MARKERS IN GLIOMAS FOLLOWING PHARMACOLOGICAL NOTCH BLOCKADE Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v65, https://doi.org/10.1093/neuonc/nou244.2
Published: 01 November 2014
